IMPAX LABORATORIES INC / AMNEAL PHARMACEUTICALS LLC / Merger / Public / £4819m

Synopsis

Merger of equals between Amneal Pharmaceuticals and Impax Laboratories, a developer, manufacturer, and marketer of bioequivalent pharmaceutical products._x000D_ _x000D_

Principals

target

Impax Laboratories

bidder

Amneal Pharmaceuticals

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (2)

charles ruck

Partner at Latham & Watkins

Lawyer

bidder

124

Deals

£ 378.50 B

Total Value

r. scott shean

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 60.82 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy